Abby Hitchens
Overview
Explore the profile of Abby Hitchens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silver S, Houghton K, Hitchens A, Ansquer V, Ciepielewska M
J Dermatol
. 2025 Jan;
52(3):416-422.
PMID: 39760298
Erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) are rare genetic disorders. There are limited data regarding how these disorders are managed in real-world settings. The aim of this study was...
2.
Dave R, Crayton H, Miravalle A, Tai M, Wyse K, Houghton K, et al.
Neurol Ther
. 2024 Oct;
13(6):1737-1745.
PMID: 39441497
Introduction: Real-world data are required to provide a greater understanding of the impact of ofatumumab on the ability to mount an effective immune response following the receipt of approved COVID-19...
3.
Kaul S, Gosmanova E, Castriota F, Hitchens A, Candrilli S, Parikh R, et al.
J Endocr Soc
. 2023 May;
7(5):bvad050.
PMID: 37153700
Hypoparathyroidism (HypoPT) is a rare disease associated with high morbidity. Its economic impact is not well understood. This retrospective, cross-sectional study used data from the United States-based National Inpatient Sample...
4.
Singal A, Nagar S, Hitchens A, Davis K, Iyer S
Cancer Rep (Hoboken)
. 2022 Jul;
6(1):e1679.
PMID: 35822407
Background: Lenvatinib monotherapy was approved in the United States for first-line treatment of patients with unresectable hepatocellular carcinoma (uHCC) in 2018. This study assessed real-world treatment patterns and outcomes of...
5.
Singal A, Nagar S, Hitchens A, Davis K, Iyer S
Clin Gastroenterol Hepatol
. 2021 Nov;
21(3):830-831.e1.
PMID: 34813942
Hepatocellular (HCC) is the most common type of primary liver cancer and the fourth most common cause of cancer-related deaths globally. Although most cases of HCC were historically attributed to...
6.
Singal A, Nagar S, Hitchens A, Davis K, Iyer S
Future Oncol
. 2021 Apr;
17(21):2759-2768.
PMID: 33832339
This study evaluated the effectiveness of lenvatinib monotherapy for first-line treatment of unresectable hepatocellular carcinoma (uHCC) in a real-world setting. This retrospective cohort study included patients who initiated lenvatinib monotherapy...